Physician profile
Andy Rodriguez
NPI 1972820330
$7,787.35
in general payments reported to CMS, 2019-2025
48 companies · $1,460 in 2025
The $1,460 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $329 · 2021: $824 · 2022: $1,333 · 2023: $1,164 · 2024: $1,969 · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,576 · Education: $17.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,576.07 |
| Education | $17.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $994.19 | 2021-2025 | Qulipta, Ubrelvy |
| Sk Life Science, INC. | $842.64 | 2021-2025 | Xcopri |
| Supernus Pharmaceuticals, INC. | $771.89 | 2019-2025 | Qelbree, Qelbree |
| Ucb, INC. | $748.62 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Neuropace, INC. | $537.79 | 2019-2023 | |
| Pfizer INC. | $401.86 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $379.99 | 2019-2022 | |
| Neurelis, INC. | $234.81 | 2021-2025 | Valtoco |
| Lundbeck LLC | $223.96 | 2022-2025 | Vyepti |
| Aucta Pharmaceuticals, INC. | $181.83 | 2024-2025 | Motpoly Xr |
| Jazz Pharmaceuticals INC. | $177.02 | 2019-2025 | Epidiolex |
| Sumitomo Pharma America, INC. | $158.49 | 2023-2024 | Aptiom |
| Novartis Pharmaceuticals Corporation | $150.80 | 2019-2021 | |
| Livanova USA, INC. | $148.00 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Scilex Pharmaceuticals INC. | $145.50 | 2023-2025 | Ztlido |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.